Cui Cui

Cui Cui joined Jefferies in Sep 2024 as Head of Asia Healthcare. The team achieved Jefferies’ first-ever No. 1 ranking in Asia Healthcare in the 2025 Extel (II) and successfully retained the top position in 2026. Cui comes with rich experience in the healthcare space for 13+ years. She spent 3 years at UBS AM as a senior analyst, leading launch of UBS China HC Equity Fund. She was at Citigroup as Head of China Healthcare Research, leading a No.1 ranking team in II Asia Healthcare five-year-in-a-row from 2017 to 2021.

What We Are Known For:

Thought leadership. Leading the Asia healthcare conversation through differentiated research, proprietary insights and unparalleled industry access.

Investor Pulse. Deep engagement with investors, management teams and industry leaders enables early identification of emerging themes and market inflection points.

Differentiated Corporate Access. Connecting investors with the region’s most influential healthcare companies and direct access to industry participants through marquee events.

Independent & High Conviction. Known for challenging consensus and identifying the key inflection points shaping healthcare investment outcomes.